Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease
- 1 February 2006
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (3) , 492-499
- https://doi.org/10.1016/j.jacc.2005.09.042
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II DyslipidemiaThe American Journal of Cardiology, 2005
- Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin TreatmentCirculation, 2005
- HDL Cholesterol and Protective Factors in AtherosclerosisCirculation, 2004
- Natural genetic variation as a tool in understanding the role of CETP in lipid levels and diseaseJournal of Lipid Research, 2003
- The Endothelium and Lipoproteins: Insights from Recent Cell Biology and Animal StudiesSeminars in Thrombosis and Hemostasis, 2000
- Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease RiskArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Scavenger receptor Bl and cholesterol traffickingCurrent Opinion in Lipidology, 1999
- Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycansAtherosclerosis, 1996
- Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.Journal of Clinical Investigation, 1996
- Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.Journal of Clinical Investigation, 1995